Dose-Escalated Robotic SBRT for Stage I-II Prostate Cancer.
Ontology highlight
ABSTRACT: Stereotactic body radiotherapy (SBRT) is the precise external delivery of very high-dose radiotherapy to targets in the body, with treatment completed in one to five fractions. SBRT should be an ideal approach for organ-confined prostate cancer because (I) dose-escalation should yield improved rates of cancer control; (II) the unique radiobiology of prostate cancer favors hypofractionation; and (III) the conformal nature of SBRT minimizes high-dose radiation delivery to immediately adjacent organs, potentially reducing complications. This approach is also more convenient for patients, and is cheaper than intensity-modulated radiotherapy (IMRT). Several external beam platforms are capable of delivering SBRT for early-stage prostate cancer, although most of the mature reported series have em
SUBMITTER: Meier R
PROVIDER: S-EPMC4387928 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature
ACCESS DATA